Cephea South America Feasibility Study
NCT: NCT07244939 · ACTIVE_NOT_RECRUITING
広告
NCT識別子NCT07244939
ステータスACTIVE_NOT_RECRUITING
開始日2025-06-17
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
概要
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。